{
    "clinical_study": {
        "@rank": "55277", 
        "acronym": "IVAS", 
        "arm_group": [
            {
                "arm_group_label": "artesunate", 
                "arm_group_type": "Experimental", 
                "description": "intravenous artesunate 80 mg/kg initially  then after 8 hours then  daily"
            }, 
            {
                "arm_group_label": "quinine", 
                "arm_group_type": "Active Comparator", 
                "description": "quinine infusion 80 mg/kg every 8 hours"
            }
        ], 
        "brief_summary": {
            "textblock": "Intravenous artesunate is egual to quinine in the treatment of severe malaria"
        }, 
        "brief_title": "Intravenous Artesunate and Malaria", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Malaria", 
        "condition_browse": {
            "mesh_term": "Malaria"
        }, 
        "detailed_description": {
            "textblock": "Intravenous artesunate is egual  to quinine in the treatment of severe malaria in the form\n      of fever clearance time and parasite clearance time"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n        severe P.falciparum malaria-\n\n        Exclusion Criteria:\n\n        mixed infection Pregnant women -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "1 Year"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 2, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01805232", 
            "org_study_id": "artesunate and malaria"
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "artesunate", 
                    "quinine"
                ], 
                "description": "intravenous artesunate 80 mg/kg initially  then after 8 hours then  daily", 
                "intervention_name": "artesunate", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "artesunate", 
                    "quinine"
                ], 
                "description": "quinine infusion 80 mg/kg every 8 hours till the patient can take orally", 
                "intervention_name": "Quinine", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Quinine", 
                "Artesunate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "severe", 
            "Falciaparum", 
            "Malaria"
        ], 
        "lastchanged_date": "March 4, 2013", 
        "location": {
            "contact": {
                "email": "ishagadamm@yahoo.com", 
                "last_name": "Abzinab A Ali, MD", 
                "phone": "+249911259199", 
                "phone_ext": "122"
            }, 
            "facility": {
                "address": {
                    "city": "Kassala", 
                    "country": "Sudan", 
                    "zip": "249"
                }, 
                "name": "Kassala"
            }, 
            "investigator": {
                "last_name": "Tajeldien A Abdulla, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Sudan"
        }, 
        "number_of_arms": "2", 
        "official_title": "Intravenous Artesunate Versus Quinine in Severe Malaria at Kassla, Sudan", 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Sudan: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "To  compare the parasite clearance time and fever clearance time between  the two  groups", 
            "measure": "clearance of the parasite and fever", 
            "safety_issue": "No", 
            "time_frame": "3 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01805232"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Khartoum", 
            "investigator_full_name": "Ishag Adam", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University of Khartoum", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "University of Kassala, Sudan", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Kassala", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Sudan", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "University of Khartoum", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2013"
    }
}